Prolonged low dose indomethacin for persistent ductus arteriosus of prematurity.

Treatment of patent ductus arteriosus with ibuprofen. Arch Dis Child Fetal Neonatal Ed (1997) 1.73

Patent ductus arteriosus in the newborn. Arch Dis Child (1993) 1.10

Indomethacin use for the management of patent ductus arteriosus in preterms: a web-based survey of practice attitudes among neonatal fellowship program directors in the United States. Pediatr Cardiol (2007) 0.90

Drug induced closure of patent ductus arteriosus. Heart (1996) 0.80

The persistently patent arterial duct in the premature infant. Images Paediatr Cardiol (2001) 0.76

Prolonged low dose indomethacin for persistent ductus arteriosus. Arch Dis Child (1991) 0.76

Pharmacologic, pharmacodynamic, and pharmacokinetic considerations with intravenous Ibuprofen lysine. J Pediatr Pharmacol Ther (2007) 0.75

Confidence intervals rather than P values: estimation rather than hypothesis testing. Br Med J (Clin Res Ed) (1986) 18.51

Effects of indomethacin in premature infants with patent ductus arteriosus: results of a national collaborative study. J Pediatr (1983) 2.65

The silent ductus: its precursors and its aftermath. Pediatr Cardiol (1986) 1.33

Prophylactic indomethacin therapy for patent ductus arteriosus in very-low-birth-weight infants. N Engl J Med (1982) 1.30

Pharmacokinetics of indomethacin in the neonate. Relation of plasma indomethacin levels to response of the ductus arteriosus. N Engl J Med (1981) 1.24

Effectiveness and pharmacokinetics of indomethacin in premature newborns with patent ductus arteriosus. Eur J Clin Pharmacol (1980) 1.23

Indomethacin, patent ductus arteriosus, and cerebral blood flow. J Pediatr (1986) 1.20

Indomethacin treatment for patent ductus arteriosus in very low birthweight infants: double blind trial. Arch Dis Child (1983) 1.17

The effect of indomethacin on cerebral blood-flow velocity in premature infants. Dev Med Child Neurol (1987) 1.14

Early administration of indomethacin to preterm infants. Arch Dis Child (1986) 1.10

Early closure of patent ductus arteriosus with indomethacin in preterm infants with idiopathic respiratory distress syndrome. Acta Paediatr Scand (1983) 1.08

Indomethacin therapy on the first day of life in infants with very low birth weight. J Pediatr (1985) 1.06

Response of the patent ductus arteriosus to indomethacin treatment. Am J Dis Child (1987) 1.05

Recurrence of symptomatic patent ductus arteriosus in extremely premature infants, treated with indomethacin. J Pediatr (1984) 1.01

Prevention of symptomatic patent ductus arteriosus with a single dose of indomethacin. J Pediatr (1987) 0.97

Effect of prolonged indomethacin therapy on renal function and selected vasoactive hormones in very-low-birth-weight infants with symptomatic patent ductus arteriosus. J Pediatr (1983) 0.96

Randomized low-dose indomethacin trial for prevention of intraventricular hemorrhage in very low birth weight neonates. J Pediatr (1988) 0.92

Introduction of plasma indomethacin level monitoring and evaluation of an effective threshold level in very low birth weight infants with symptomatic patent ductus arteriosus. Eur J Pediatr (1983) 0.91

Administration of indomethacin for the prevention of periventricular-intraventricular hemorrhage in high-risk neonates. J Pediatr (1988) 0.90

Disposition of indomethacin in preterm infants. J Pediatr (1979) 0.89

Early intravenous indomethacin prolongs respiratory support in very low birth weight infants. Acta Paediatr Scand (1987) 0.89

Plasma indomethacin levels in preterm newborn infants with symptomatic patent ductus arteriosus--clinical and echocardiographic assessments of response. J Pediatr (1979) 0.86

Prolonged indomethacin treatment in preterm infants with symptomatic patent ductus arteriosus: efficacy, drug level monitoring, and patient selection. Eur J Pediatr (1987) 0.85

Timing of indomethacin therapy in persistent ductus. Lancet (1980) 0.85

Recovery of prostaglandin production associated with reopening of the ductus arteriosus after indomethacin treatment in preterm infants with respiratory distress syndrome. Pediatr Pharmacol (New York) (1982) 0.82

Effects of prolonged versus acute indomethacin therapy in very low birth-weight infants with patent ductus arteriosus. Eur J Pediatr (1988) 0.81

Survival and morbidity in a geographically defined population of low birthweight infants. Lancet (1986) 3.30

Cost of neonatal intensive care for very-low-birthweight infants. Lancet (1986) 3.08

Birthweight specific trends in cerebral palsy. Arch Dis Child (1990) 2.56

Trends in birth prevalence of cerebral palsy. Arch Dis Child (1987) 2.34

Attention deficit hyperactivity disorders and other psychiatric outcomes in very low birthweight children at 12 years. J Child Psychol Psychiatry (1997) 2.26

Motor skills in extremely low birthweight children at the age of 6 years. Arch Dis Child (1989) 2.11

Factors associated with periventricular haemorrhage in very low birthweight infants. Arch Dis Child (1981) 2.01

Blood pressure and cerebral haemorrhage and ischaemia in very low birthweight infants. Early Hum Dev (1989) 1.95

Clinical and subclinical deficits at 8 years in a geographically defined cohort of low birthweight infants. Arch Dis Child (1994) 1.85

Receiver operating characteristic curves for comparison of serial neutrophil band forms and C reactive protein in neonates at risk of infection. Arch Dis Child (1992) 1.80

Registering a fetus papyraceus. Registration is important for research into cerebral palsy. BMJ (1997) 1.75

Head circumference as an index of brain weight in the fetus and newborn. Early Hum Dev (1977) 1.74

Prevalence of behaviour disorders in low birthweight infants. Arch Dis Child (1994) 1.67

A hypothesis for the aetiology of spastic cerebral palsy--the vanishing twin. Dev Med Child Neurol (1997) 1.64

Ethamsylate reduces the incidence of periventricular haemorrhage in very low birth-weight babies. Lancet (1981) 1.59

Outbreak of cephalosporin resistant Enterobacter cloacae infection in a neonatal intensive care unit. Arch Dis Child (1987) 1.54

In utero transfer to specialist centres. Arch Dis Child (1983) 1.54

Predicting costs and outcomes of neonatal intensive care for very low birthweight infants. Public Health (1991) 1.41

Multicentre trial of ethamsylate for prevention of periventricular haemorrhage in very low birthweight infants. Lancet (1986) 1.40

Effects of birth weight, gestational age, and maternal obstetric history on birth prevalence of cerebral palsy. Arch Dis Child (1987) 1.37

Cognitive and educational outcome of very-low-birthweight children in early adolescence. Dev Med Child Neurol (1998) 1.36

Growth impairment in very low birthweight children at 12 years: correlation with perinatal and outcome variables. Arch Dis Child Fetal Neonatal Ed (1996) 1.36

Motor impairment in children 12 to 13 years old with a birthweight of less than 1250 g. Arch Dis Child Fetal Neonatal Ed (1995) 1.34

Ultrasound examination of neonatal heads. Lancet (1979) 1.33

Transfer before delivery on Merseyside: an analysis of the first 140 patients. Br J Obstet Gynaecol (1983) 1.33

Cost of care for a geographically determined population of low birthweight infants to age 8-9 years. II. Children with disability. Arch Dis Child Fetal Neonatal Ed (1996) 1.31

The incidence of renal calcification in preterm infants. Arch Dis Child (1991) 1.27

Early prognosis of low birthweight infants treated for progressive posthaemorrhagic hydrocephalus. Arch Dis Child (1983) 1.27

Visual impairment in very low birthweight children. Arch Dis Child Fetal Neonatal Ed (1997) 1.24

High-titre anti-CMV plasma in treatment of neonatal cytomegalovirus infection. Lancet (1984) 1.24

Costs and benefits of neonatal intensive care. Arch Dis Child (1988) 1.22

Serious infection in a neonatal intensive care unit: a two-year survey. J Hyg (Lond) (1985) 1.20

Selective decontamination with nystatin for control of a Candida outbreak in a neonatal intensive care unit. J Hosp Infect (1993) 1.14

Cost of care for a geographically determined population of low birthweight infants to age 8-9 years. I. Children without disability. Arch Dis Child Fetal Neonatal Ed (1996) 1.13

Referral to a regional centre improves outcome in extremely low birthweight infants. Arch Dis Child (1987) 1.13

Early administration of indomethacin to preterm infants. Arch Dis Child (1986) 1.10

Klebsiella infection in a neonatal intensive care unit: role of bacteriological surveillance. J Hosp Infect (1984) 1.10

Characteristics of a beta-lactamase produced by Clostridium butyricum. J Antimicrob Chemother (1982) 1.09

Differential effects of preterm birth and small gestational age on cognitive and motor development. Arch Dis Child Fetal Neonatal Ed (1997) 1.09

Hazards of analgesia for newborn infants. Arch Dis Child (1988) 1.05

Nursing staff requirements for neonatal intensive care. Arch Dis Child (1993) 1.03

Prophylactic ethamsylate for periventricular haemorrhage. Arch Dis Child (1984) 0.99

A technique for the non-invasive estimation of cerebral blood flow in the newborn infant. J Med Eng Technol (1977) 0.99

Neurodevelopmental outcome in meningococcal disease: a case-control study. Arch Dis Child (2001) 0.99

Randomised trial of routine versus selective paralysis during ventilation for neonatal respiratory distress syndrome. Arch Dis Child (1993) 0.98

Ceftazidime or gentamicin plus benzylpenicillin in neonates less than forty-eight hours old. J Antimicrob Chemother (1983) 0.98

Does phenobarbitone prevent periventricular hemorrhage in very low-birth-weight babies?: a controlled trial. Pediatrics (1982) 0.97

Poor response to oral indomethacin therapy for persistent ductus arteriosus in very low birthweight infants. Br Heart J (1979) 0.97

Birthweight-specific risk factors for necrotising enterocolitis. J Epidemiol Community Health (1987) 0.96

Infection and colonisation of neonates by Hansenula anomala. Lancet (1986) 0.94

Improving head growth in very preterm infants--a randomised controlled trial I: neonatal outcomes. Arch Dis Child Fetal Neonatal Ed (2008) 0.94

Ethamsylate reduces immunoreactive prostacyclin metabolite in low birthweight infants with respiratory distress syndrome. Early Hum Dev (1986) 0.92

Handedness in very-low-birthweight (VLBW) children at 12 years of age: relation to perinatal and outcome variables. Dev Med Child Neurol (1996) 0.92

Cerebral palsy in low-birthweight infants. II. Spastic diplegia: associations with fetal immaturity. Dev Med Child Neurol (1988) 0.91

Ligation of patent ductus arteriosus in the very low birthweight newborn infant. Arch Dis Child (1978) 0.91

Adriamycin and cisplatin for hepatoblastoma. Cancer (1985) 0.91

Why do so many small infants develop an inguinal hernia? Arch Dis Child (1986) 0.90

Determinants of major handicap in post-haemorrhagic hydrocephalus. Arch Dis Child (1987) 0.90

Necrotising enterocolitis after cardiac catheterisation in infants. Arch Dis Child (1980) 0.90

Cerebral palsy in low-birthweight infants. I. Spastic hemiplegia: associations with intrapartum stress. Dev Med Child Neurol (1988) 0.88

Comparison of urinary and plasma malondialdehyde in preterm infants. Clin Chim Acta (1997) 0.88

Transcutaneous carbon dioxide monitoring. Arch Dis Child (1990) 0.88

Breath pentane as a marker for lipid peroxidation and adverse outcome in preterm infants. Arch Dis Child Fetal Neonatal Ed (1998) 0.88

Maturation of the neonatal somatosensory evoked response in preterm infants. Dev Med Child Neurol (1988) 0.87

Does total antioxidant status relate to outcome in very preterm infants? Clin Sci (Lond) (1998) 0.87

Elevated levels of immunoreactive prostacyclin metabolite in babies who develop intraventricular haemorrhage. Acta Paediatr Scand (1987) 0.87

Necrotizing enterocolitis complicating the management of posthemorrhagic hydrocephalus. J Pediatr Surg (1993) 0.87

Urinary 8-hydroxydeoxyguanosine in infants and children. Free Radic Res (1998) 0.86

Bacteroides fragilis septicaemia and meningitis in early infancy. Arch Dis Child (1975) 0.86

Randomised controlled trial of allopurinol prophylaxis in very preterm infants. Arch Dis Child Fetal Neonatal Ed (1995) 0.85

Systemic candidiasis. Arch Dis Child (1982) 0.85

Pentane measurement in ventilated infants using a commercially available system. Free Radic Biol Med (1997) 0.85

Survival and cerebral morbidity in preterm infants. Lancet (1994) 0.83

Candida albicans skin abscesses. Arch Dis Child (1984) 0.82

Familial congenital heart block and hydrops fetalis. Arch Dis Child (1980) 0.82

Pneumothorax, mechanical ventilation, and periventricular haemorrhage. Lancet (1981) 0.82

Hyponatraemia caused by repeated cerebrospinal fluid drainage in post haemorrhagic hydrocephalus. Arch Dis Child (1983) 0.81

Neonatal cranial ultrasound and neurological development at follow-up. Lancet (1985) 0.81

Short-latency cortical somatosensory evoked responses of preterm infants with ultrasound abnormality of the brain. Dev Med Child Neurol (1988) 0.80

Cranial ultrasound assessment of gestational age in low birthweight infants. Arch Dis Child (1989) 0.79

Micromethod for bleeding time in the newborn. Arch Dis Child (1985) 0.78

Plasma hypoxanthine: a marker for hypoxic-ischaemic induced periventricular leucomalacia? Arch Dis Child (1992) 0.78

Laterality and prematurity. Arch Dis Child (1989) 0.78

Improved survival and neurodevelopmental outcome after prolonged ventilation in preterm neonates who have received antenatal steroids and surfactant. Arch Dis Child Fetal Neonatal Ed (2001) 0.78

How accurate are the perinatal statistics for your region? Community Med (1987) 0.77

Somatosensory evoked potentials following posterior tibial nerve stimulation predict later motor outcome. Dev Med Child Neurol (1994) 0.77

Renal blood flow velocity in acute renal failure following cardiopulmonary bypass surgery. Acta Paediatr (1998) 0.77

Timing of neonatal cerebroventricular haemorrhage with ultrasound. Arch Dis Child (1982) 0.76

Maturation of the cortical evoked response to posterior-nerve stimulation in the preterm neonate. Dev Med Child Neurol (1989) 0.76

Electrolytes and glucose in cerebrospinal fluid of premature infants with intraventricular haemorrhage: role of potassium in cerebral infarction. Arch Dis Child (1989) 0.75

Nutrition and bronchopulmonary dysplasia. Arch Dis Child (1991) 0.75

Chromosomal defects and caesarean birth. Arch Dis Child (1987) 0.75

Tranexamic acid in the prevention of periventricular haemorrhage. Arch Dis Child (1984) 0.75

Establishment of an intermediate care ward for babies and mothers. Arch Dis Child (1987) 0.75

Five year outcome of preterm sextuplets related to size at birth. Arch Dis Child (1990) 0.75

Epidemiology of strawberry haemangioma in low birthweight infants. Br J Dermatol (1987) 0.75

Congenital non-chylous pleural effusion with Down's syndrome. J Med Genet (1987) 0.75

Convexity cerebral haemorrhage in the neonate: in vivo ultrasound diagnosis. Arch Dis Child (1983) 0.75

Childhood febrile convulsions. Lancet (1994) 0.75

Clinical trials and P values. Pediatrics (1993) 0.75